• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Dysthyroid optic neuropathy (DON).

作者信息

Ebner Roberto

机构信息

Neuro-ophthalmology Unit, British Hospital of Buenos Aires, Finochietto 1700, C1275 AAJ, Buenos Aires, Argentina.

出版信息

Semin Ophthalmol. 2002 Mar;17(1):18-21. doi: 10.1076/soph.17.1.18.10289.

DOI:10.1076/soph.17.1.18.10289
PMID:15513451
Abstract

Dysthyroid Optic Neuropathy (DON) affects a small percentage of patients with Graves disease, but, when it occurs, it can cause significant and permanent loss of vision. DON is treatable if recognized early. Systemic steroids can be effective, but may cause side affects. Orbital injection of steroids may play a role in selected patients. Orbital radiation has a more permanent effect and has gained wide acceptance as a relatively non-invasive method of reversing DON. Surgery to decompress crowded orbits has been used for years and continues to be a viable approach for those patients with optic neuropathy, especially when there is significant proptosis. Optic nerve decompression can also be achieved through a transethmoidal approach.

摘要

相似文献

1
Dysthyroid optic neuropathy (DON).
Semin Ophthalmol. 2002 Mar;17(1):18-21. doi: 10.1076/soph.17.1.18.10289.
2
Dysthyroid orbitopathy and orbital decompression. A review.甲状腺功能异常性眼眶病与眼眶减压术。综述。
Acta Otorhinolaryngol Belg. 1992;46(3):303-9.
3
[Optic neuropathy in Basedow's disease].[突眼性甲状腺肿中的视神经病变]
Schweiz Rundsch Med Prax. 1987 Jul 14;76(29):825-9.
4
[Dysthyroid optic neuropathy. Apropos of 2 cases].[甲状腺功能异常性视神经病变。附2例报告]
J Fr Ophtalmol. 1996;19(8-9):543-50.
5
Selective endoscopic decompression of the orbital apex for dysthyroid optic neuropathy.甲状腺功能障碍性视神经病变的选择性内镜下眶尖减压术
Laryngoscope. 2009 Jun;119(6):1236-40. doi: 10.1002/lary.20240.
6
Course of pattern-reversed visual evoked cortical potentials in 30 eyes after bony orbital decompression in dysthyroid optic neuropathy.甲状腺相关眼病视神经病变行眼眶骨减压术后 30 眼视诱发电位图形反转的病程。
Br J Ophthalmol. 2011 Feb;95(2):222-6. doi: 10.1136/bjo.2009.173658. Epub 2010 Jun 28.
7
Clinical and Visual Outcomes of Dysthyroid Optic Neuropathy After Surgical Orbital Decompression.甲状腺相关眼病术后视神经病变的临床和视觉结局。
Thyroid. 2023 Jun;33(6):743-751. doi: 10.1089/thy.2022.0564. Epub 2023 May 22.
8
Transcaruncular orbital decompression for dysthyroid optic neuropathy.经泪阜眼眶减压术治疗甲状腺相关眼病性视神经病变
Ophthalmic Plast Reconstr Surg. 2003 Sep;19(5):353-8. doi: 10.1097/01.IOP.0000083645.19368.99.
9
[Orbital-bony decompression in patients with dysthyroid orbitopathy--first Croatian experiences].[甲状腺功能障碍性眼眶病患者的眼眶减压术——克罗地亚的首次经验]
Acta Med Croatica. 2006;60(2):83-6.
10
Endoscopic orbital decompression for Graves' ophthalmopathy.Graves眼病的内镜下眼眶减压术。
Isr Med Assoc J. 2004 Nov;6(11):673-6.

引用本文的文献

1
Effect of orbital decompression on dysthyroid optic neuropathy: A retrospective case series.眼眶减压术对甲状腺相关眼病性视神经病变的影响:一项回顾性病例系列研究。
Medicine (Baltimore). 2019 Jan;98(3):e14162. doi: 10.1097/MD.0000000000014162.
2
Thyroid-stimulating immunoglobulins indicate the onset of dysthyroid optic neuropathy.促甲状腺素受体刺激性抗体提示甲状腺功能异常性视神经病变的发生。
J Endocrinol Invest. 2015 Jul;38(7):769-77. doi: 10.1007/s40618-015-0254-2. Epub 2015 Mar 4.
3
Evaluation of multifocal visual evoked potentials in patients with Graves' orbitopathy and subclinical optic nerve involvement.
格雷夫斯眼眶病合并亚临床视神经受累患者的多焦视觉诱发电位评估
Doc Ophthalmol. 2012 Aug;125(1):11-9. doi: 10.1007/s10633-012-9325-2. Epub 2012 May 13.
4
The optic nerve head in acquired optic neuropathies.获得性视神经病变中的视神经头。
Nat Rev Neurol. 2010 Apr;6(4):221-36. doi: 10.1038/nrneurol.2010.5. Epub 2010 Mar 9.
5
Dysthyroid optic neuropathy: a clinical diagnosis or a definable entity?甲状腺功能异常性视神经病变:临床诊断还是可明确界定的实体?
Br J Ophthalmol. 2007 Apr;91(4):409-10. doi: 10.1136/bjo.2006.110932.